SEC Form 4 · accession 0001209191-16-150333
EXACT SCIENCES CORP · EXAS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maneesh Arora
Officer — COO · Director
Period of report
Nov 11, 2016
Accepted (ET)
Nov 15, 2016 · 8:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124140
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2016 | M | 562,932 | $0.83 | A | 1,094,309 | D | |
| Common StockF1 | Nov 11, 2016 | S | 50,000 | $17.68 | D | 1,044,309 | D | |
| Common StockF2 | Nov 14, 2016 | S | 256,466 | $17.52 | D | 787,843 | D | |
| Common StockF3 | Nov 15, 2016 | S | 256,466 | $17.36 | D | 531,377 | D | |
| Common Stock | holding | — | — | — | 12,359 | I | Held in 401(K) Account | |
| Common Stock | holding | — | — | — | 65,000 | I | Held in Grantor Retained Annuity Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.83 | Nov 11, 2016 | M | 562,932 | D | Mar 18, 2013 | Mar 18, 2019 | Common Stock | 562,932 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.60 to $17.75, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.10 to $17.79, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.20 to $17.56, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.